Back to Search
Start Over
The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein
- Source :
- Thrombosis Research. 119:79-84
- Publication Year :
- 2007
- Publisher :
- Elsevier BV, 2007.
-
Abstract
- It is well demonstrated that obesity is an independent risk factor for cardiovascular diseases. Recent studies have shown that obesity, insulin resistance and atherosclerosis are closely related phenomena in which low-grade inflammatory state and prothrombotic condition has pivotal roles. It has been shown that CD40-soluble CD40 ligand (sCD40L) interactions might constitute an important mediator for vascular inflammation. The aim of the present study was to assess sCD40L in relation to hs-CRP and cardiovascular risk factors in relation to body mass index (BMI).Serum sCD40L and hs-CRP concentrations were measured in 52 obese patients and 28 non-obese subjects by ELISA. Insulin resistance was calculated by homeostasis model assessment-insulin resistance (HOMA-IR). We divided the participants into three groups depending in their BMI levels (Group 1: BMI25 kg/m(2), Group 2: BMI 30-34.9 kg/m(2), Group 3: BMIor =35 kg/m(2)).We determined that the mean sCD40L of group 3 was significantly higher than group 1 and group 2 (p0.05, p0.05, respectively). However, there was no significant correlation between plasma sCD40L levels and BMI. Plasma levels of hs-CRP were higher in obese group than the non-obese group (p0.001). The levels of sCD40L were not significantly different between the two groups. The mean hs-CRP levels increased gradually in accordance with groups of BMI, there was a strong correlation between hs-CRP levels and BMI (r=0.724, p0.001). There was no significant correlation between sCD40L and hs-CRP levels in all participants.It is still a subject for debate whether sCD40L levels are increased or not in obesity. However, the results of this study showed that sCD40L is substantially increased in patients with severe obesity. In terms of causality, the relatively small sample size and cross-sectional design of this study are considered to be the limitation factors.
- Subjects :
- Adult
Male
medicine.medical_specialty
medicine.medical_treatment
CD40 Ligand
Enzyme-Linked Immunosorbent Assay
Inflammation
Body Mass Index
Waist–hip ratio
Insulin resistance
Risk Factors
Internal medicine
medicine
Humans
Obesity
CD40 Antigens
Risk factor
biology
business.industry
Insulin
C-reactive protein
Hematology
Atherosclerosis
medicine.disease
C-Reactive Protein
Endocrinology
Cardiovascular Diseases
biology.protein
Female
medicine.symptom
business
Body mass index
Biomarkers
Subjects
Details
- ISSN :
- 00493848
- Volume :
- 119
- Database :
- OpenAIRE
- Journal :
- Thrombosis Research
- Accession number :
- edsair.doi.dedup.....bedd9f46f2a8e60f735fcc4d492bd1a3
- Full Text :
- https://doi.org/10.1016/j.thromres.2005.12.019